CHRONIC VAGUS NERVE-STIMULATION INCREASES THE LATENCY OF THE THALAMOCORTICAL SOMATOSENSORY EVOKED-POTENTIAL

被引:35
作者
NARITOKU, DK
MORALES, A
PENCEK, TL
WINKLER, D
机构
[1] SO ILLINOIS UNIV,SCH MED,DEPT PHARMACOL,SPRINGFIELD,IL 62794
[2] SO ILLINOIS UNIV,SCH MED,DEPT PEDIAT,SPRINGFIELD,IL 62794
[3] SO ILLINOIS UNIV,SCH MED,DIV NEUROSURG,SPRINGFIELD,IL 62794
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1992年 / 15卷 / 10期
关键词
VAGUS NERVE STIMULATION; BRAIN STEM; SEIZURE; EPILEPSY; SUBCORTICAL EVOKED POTENTIALS;
D O I
10.1111/j.1540-8159.1992.tb02935.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Neurocybernetic Prosthesis (NCP) is a pacemaker-like device that has been designed to provide chronic intermittent vagus nerve stimulation. It is currently under study for the treatment of refractory partial onset epilepsy, and preliminary studies have indicated that partial onset seizures are improved by this therapy. The mechanisms by which it exerts its antiepileptic effect are not well understood. Although there are extensive pathways to the forebrain from the nuclei of the vagus nerve, the evidence that the NCP alters neural transmission outside the vagal system is limited. We prospectively examined somatosensory and brain stem auditory evoked potentials (BAEPs) in three patients receiving NCP implantation to determine if changes in these studies occur as a result of chronic vagus nerve stimulation. The results demonstrate a significant prolongation of the cervicomedullary to thalamocortical potential (N13-N20) interval on somatosensory evoked potential (SSEP) studies following activation of the device. No other significant changes were seen on SSEP or BAEP in the NCP implanted patients or normal controls. The findings suggest that chronic vagus nerve stimulation does alter neuronal networks outside of the brain stem vagus system, and may potentially provide a means to clinically monitor and titrate this therapy.
引用
收藏
页码:1572 / 1578
页数:7
相关论文
共 24 条
[1]  
CHASE MICHAEL H., 1967, BRAIN RES, V5, P236, DOI 10.1016/0006-8993(67)90089-3
[2]   NORADRENERGIC ABNORMALITIES IN THE CENTRAL-NERVOUS-SYSTEM OF SEIZURE-NAIVE GENETICALLY EPILEPSY-PRONE RATS [J].
DAILEY, JW ;
MISHRA, PK ;
KO, KH ;
PENNY, JE ;
JOBE, PC .
EPILEPSIA, 1991, 32 (02) :168-173
[3]  
Fromm GH, 1987, EPILEPSY RETICULAR F
[4]  
GREEN JB, 1982, EPILEPSIA, V32, P417
[5]   VAGUS NERVE-STIMULATION IN HUMANS - NEUROPHYSIOLOGICAL STUDIES AND ELECTROPHYSIOLOGICAL MONITORING [J].
HAMMOND, EJ ;
UTHMAN, BM ;
REID, SA ;
WILDER, BJ ;
RAMSAY, RE .
EPILEPSIA, 1990, 31 :S51-S59
[6]   SUBSTANTIA NIGRA - SITE OF ANTICONVULSANT ACTIVITY MEDIATED BY GAMMA-AMINOBUTYRIC ACID [J].
IADAROLA, MJ ;
GALE, K .
SCIENCE, 1982, 218 (4578) :1237-1240
[7]   CENTRAL ADRENERGIC-RECEPTOR CHANGES IN THE INHERITED NORADRENERGIC HYPERINNERVATED MUTANT MOUSE TOTTERING [J].
LEVITT, P ;
LAU, C ;
PYLYPIW, A ;
ROSS, LL .
BRAIN RESEARCH, 1987, 418 (01) :174-177
[8]   FEASIBILITY AND SAFETY OF VAGAL-STIMULATION IN MONKEY MODEL [J].
LOCKARD, JS ;
CONGDON, WC ;
DUCHARME, LL .
EPILEPSIA, 1990, 31 :S20-S26
[9]   SEIZURES EVOKED FROM AREA TEMPESTAS ARE SUBJECT TO CONTROL BY GABA AND GLUTAMATE RECEPTORS IN SUBSTANTIA NIGRA [J].
MAGGIO, R ;
GALE, K .
EXPERIMENTAL NEUROLOGY, 1989, 105 (02) :184-188
[10]  
MCNAMARA JO, 1984, J NEUROSCI, V4, P2410